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This paper examines the links between the rhythm of knowledge generation, the 
types of actors involved in knowledge generation and the structure of networks of 
collaborations in the biotech sector. The analysis departs from all biotechnology 
patent applications covered by Derwent Biotechnology Abstracts (DBA). In 2001, 
more than 96,000 patents are reported in DBA, covering 40 intellectual property 
authorities. First, the number of patent applications is continuously increasing, though 
the number of radical innovations (new technological arrangements) reaches rapidly 
a steady state. Second, both the number of actors and the number of collaborations 
follow a bell shape, thus seeming to positively correlate with the rate of technological 
change 
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1. INTRODUCTION 
Industry Life Cycle theories have launched a vigorous research program studying the forces governing 
the evolution of industrial structures (Abernathy and Utterback, 1978, Utterback and Abernathy, 
1975). As such, they challenge the traditional approach of industrial organisation by underlying the 
intrinsically changing nature of industries. Evidently, industry structures evolve on the basis of market 
selection. However, as technologies and competencies mobilised in a given production chain do 
change, firms ought to devote additional resources in learning and eventually in mastering new 
knowledge. Less efficient actors are not only those that fail in implementing their own production 
function in the short run. The may also be those that fail in modifying it in the long run (March, J. G., 
1991b). 
Fundamentally, life cycle theories exhibit two major phases in industry development, each being 
related to the state of the technological paradigm at stake (Dosi, 1982, Tushman and Anderson, 1986). 
While the first phase is characterised by radical and rapid technical change, the second reveals some 
sort of technological consolidation and stabilisation around a dominant design  (Anderson and 
Tushman, 1990). The rising recognition of the role of knowledge in industries may well be associated 
with the corresponding emergence of the so-called knowledge base literature (Afuah, A. N. and 
Utterback, 1997a). Briefly, this fruitful research avenue emphasises the fact that firms must engage in 
a wide variety of learning processes (Malerba, F., 1992) not only to improve their on-going production 
process or innovate with new products, but also to cope with rapidly changing technological 
landscapes. In fact, this has quite important implications in knowledge intensive industries, for 
mastering a wide range of scientific and technical knowledge often proves unachievable for one 
isolated organisation. Instead, firms would rely on extra-organisational arrangements, supporting the 
view that firms are not isolated islands of production (Richardson, 1972). Empirical facts strongly 
support the view that firms are embedded in complex networks of alliances and collaborations. Behind 
the explanation of why firms establish ties lies the assumption that firms naturally benefit from the 
complementarity of their partners' assets and competencies (Hite and Hesterly, 2001). Several studies 
tend to show that profoundly interacting firms tend to achieve higher levels of performance (Powell, 
Koput and Smith-Doerr, 1996a). In fact, it is not the mere number of alliances that prove important. 
Rather, the firm's central position and the density of its network boost their innovative performance, 
their market value and their operating income (Afuah, A. N. and Utterback, 1997a, Baum, Calabrese 
and Silverman, 2000, Stuart, 2000, Stuart, Hwang and Hybels, 1999).  
While the benefits drawn from networking are gradually recognised in the economic literature, much 
less is known regarding the temporary or permanent structure, or even presence, of networks. Put 
differently, ought networks to disappear with the stabilisation of industry structure, or do they express 
a new form of industrial organisation on its own? In the absence of clear empirical evidence, two 
substitutive views are confronted. Tenants of the former view posit that inter-organisational alliances 
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represent a solution for firms as to cope with the instability of the technological environment. As 
technologies settle down, the need for external alliances becomes more blurred. Arms length contracts 
may well prove more efficient economically, and the underlying industrial organisation concentrates 
around the traditional distinction between markets and hierarchies. Eventually, networks ought to 
naturally evaporate. Tenants of the continuity of networks hold the opposite assumption that the very 
nature of technologies implies systematic ties, alliances and collaborations amongst various types of 
actors. Here, networks constitute a substantive form of organisational structure by itself, 
complementary to the traditional distinction between markets and hierarchies (Orsenigo, Pammolli and 
Riccaboni, 2001, Orsenigo et al., 1998). In a way, the two contradictory propositions differ in the 
assumption regarding the changing nature of technology. While the former pictures technology as 
following a specified path of non-linear but expected consolidation, the latter states that technology on 
its own has become intrinsically complex, profoundly rooted in the so-called knowledge base 
economy.  
Thus, a natural way to explore both views is to tackle the evolution of a given technology and explore 
the actual network structure of the main actors involved in it. The objective of this paper is hence to 
analyse the links between the rhythm of knowledge creation, the types of actors involved in 
knowledge generation and the structure of networks of technological collaborations. The analysis, 
results, and conclusions shall be concerned with intra-paradigmatic knowledge dynamics exclusively. 
We define the latter in terms of rate, novelty, and conditions of knowledge combination within one of 
the most important technological breakthrough of the twentieth century: biotechnology. Operational 
measures are derived using patent statistics applied for between 1975 and 1998. The research is 
organised as follows. Section 2 reviews the theoretical and empirical literature as a background for the 
elaboration of four propositions of research. In section 3, we expose the data and method used in our 
fieldwork. The statistical results are commented in section 4. Two main results are exposed. First, the 
number of patent applications is continuously increasing, though the number of radical innovations 
(new technological arrangements) reaches rapidly a steady state. Second, both the number of actors 
and the number of collaborations follow a bell shape, thus seeming to positively correlate with the rate 
of technological change. Section 5 discusses and concludes the paper.  
2.  LITERATURE REVIEW AND HYPOTHESES DEVELOPMENT 
From exploration to exploitation 
During the past three decades, propositions concerning technological evolution have been advanced as 
to provide a plausible explanation of the sources of the so-called industrial life cycle. In this vein, 
concepts like dominant design (Utterback and Abernathy, 1975), technological trajectories and 
regimes (Nelson, R. R. and Winter, 1982a) technological guideposts (Sahal, 1981) and technological 
paradigm (Dosi, 1982) illustrate the idea that processes of knowledge generation and exploitation do 
not follow linear paths. Importantly, such studies of technical change insist on the idea that the 
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accumulation of knowledge follows different, cyclical phases rather than the mere linear process of 
knowledge accumulation.  
Perhaps the major feature of technological discontinuities is to introduce both new questions and their 
associated set of techniques that challenge pre-existing methods of doing science and/or using 
techniques. Two research traditions, or paradigms, can therefore compete on the basis of their unit of 
analysis, the set of techniques that is associated to it, leading to competing explanation of similar 
phenomena. Technological discontinuities occur at specific stages of knowledge development. Radical 
change is expressed when such discontinuities challenge and partially invalid traditional paradigms. 
But within the new paradigm, different methods may as well compete with one another. In other 
words, time for knowledge exploration and refinement is still needed in order to set standardised 
procedures of knowledge exploitation.    
The above remarks suggest that intra-paradigmatic knowledge development follows at least two 
different and probably successive phases. The first one is characterised by fast knowledge creation. 
New procedures are explored. New technological combinations are frequently introduced in the 
technological system as to determine their respective effectiveness. But as new knowledge piles up, 
the marginal improvement is meant to decrease overtime. That is, new technologies tend to only 
marginally improve the existing intra-paradigmatic stock of knowledge. Here, the technological 
system moves onto the second stage, i.e. the establishment of a dominant design. A design is said to be 
dominant when its utilisation prevails over that of other knowledge (Anderson and Tushman, 1990). 
Importantly, the establishment of a dominant design refers to the economic production and 
commercialisation of technologies. Nelson and Winter (Nelson, R.R. and Winter, 1982b) define a 
technological regime as a particular combination of fundamental properties of technologies: 
opportunity and appropriability conditions, degrees of cumulativeness of technological knowledge, 
and characteristics of the relevant knowledge in use. Importantly, these properties go hand in hand 
with the development of the scientific sphere of knowledge development. It posits that the 
technological regime follows a similar dynamic as knowledge creation reaches an asymptote. Thus we 
advance: 
P1: As the industry matures, the rhythm of knowledge creation is slowing down. 
Taken as it stands, the above proposition must be linked to more economic phenomena. In fact, the 
important idea here is that technical change is directly interacting with industrial structures. New firms 
may well be created and might subsequently grow on the basis of their distinctive technological skills, 
gaining access to preferable positions on new market segments. By way of consequence, the 
emergence of a new paradigm may potentially destroy the traditional industrial barriers to entry, thus 
representing a threat to incumbents. Therefore, the development of knowledge, or say technologies, 
should not be thought of as given for, or provided to, incumbents of a particular industry. Rather, firms 
must devote efforts in implementing learning strategies as to keep up to date with relevant knowledge 
and techniques. Likewise, the establishment of a new dominant design calls for knowledge 
exploitation more than knowledge exploration.  As March pointed out (March, J., 1991a), firms 
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aiming at diversifying their knowledge base might be better fitted in adapting in and to an unstable 
environment. Yet with the stabilisation of the technological environment, exploitation strategies, i.e. 
the ongoing use of the firm’s knowledge base (Vermeulen and Barkema, 2001) helps the organisation to 
refine its routines and allows it to recoup initial investments and to become profitable. Thus during the 
exploitation phase, firms focus on the knowledge that contributes most to its success, and filters out 
knowledge and routines that are less successful. 
In this line of thought, one can also say that the firms' knowledge base reflects to some extend the state 
of the technological environment in which firms are embedded (Afuah, A. N. and Utterback, 1997a). 
When a dominant design appears, the choice between the different hypotheses explored reduces 
drastically. Thus firms might prefer to concentrate on their internal capabilities and improvements of 
existing capabilities, stemming from the integration of bodies of knowledge whose services has proven 
more profitable.  Likewise, Malerba and Orsenigo (Malerba, F.; and Orsenigo, 1997) identify two 
patterns of innovation, namely Schumpeter Mark I and Schumpeter mark II. Schumpeter mark I is 
characterised by the creative destruction with technological ease of entry. In this setting, entrepreneurs 
and new firms play a major role in renewing industrial knowledge and by reaching higher innovative 
performances. Conversely, Schumpeter mark II is characterised by creative accumulation with the 
prevalence of large established firms and the presences of relevant barriers to entry for new 
innovators. Thus the authors show that both the industry structure and the nature of innovative 
activities are related to specific ways of accumulating knowledge. While Schumpeter Mark I relates to 
the first phase of intra-paradigmatic knowledge development, Schumpeter Mark II relates more to the 
second phase, namely that of consolidation. Importantly, the latter leads to an opposite move on the 
industry structure. Firms' growth, be it in terms of size or by means of acquisition or mergers, leads to 
an industrial shakeout (Klepper, 1997). That is, a substantial number of firms exit the industry, while 
survivors take stock of their past successes. This leads us to our second proposition:  
P2: As the sector matures, the number of actors tends to diminish 
Proposition 1 and 2 stem from the stylised facts derived from both theories and empirical analysis of 
the industry life cycle. Such theories provide a convincing account of how and why industries do 
evolve overtime, underlying the role of industrial knowledge and competencies and revealing the 
changing number of actors involved in the very course of market competition. Nevertheless, they tend 
to downplay the role of other actors that might as well prove central to relevant technological 
trajectories. Our main contention here is that academia is often the source of technical change, 
stemming from scientific developments of peculiar disciplines. As such, not only the notion of 
technological paradigms is similar to that of scientific paradigm (Kuhn, 1970), but both do not 
represent independent spheres of actors (Murray, 2001). Rather, both go closely intertwined and 
converse on the basis of their scientific and technical content. 
Recently, there has been a substantial rise in the number of contribution revealing the economic role of 
academia (Brooks, 1994, Gibbons et al., 1994, Mansfield, 1995). Such contributions state that it is 
nowadays difficult to establish a clear frontier between academia and industries. The underlying 
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reasons are multifold. First, the intensification of knowledge intensive activities has contested the 
traditional separation between fundamental and applied knowledge (Nelson, R., 1959). Firms mobilise 
both fundamental and applied knowledge in the very conduct of their productive activities. Thus, both 
the sequential and institutional distinction between an academic sphere initially concentrating on the 
creation of fundamental knowledge and an economic sphere subsequently exploiting applied 
knowledge can no longer hold. Second, public and private research laboratories have developed tight 
linked irrespective of the industry at stake. The past two decades have witnessed a considerable 
upsurge in research and development (R&D) collaborations throughout market economies that 
transcend the traditional partition between both spheres. A third important consequence of such view 
is the rejection of sequential phases of knowledge development. Rather, both academia and firms play 
a central role of all knowledge development, from fundamental to applied knowledge and vice versa.  
We do not intend to contest such well-accepted phenomena. We do also acknowledge the fundamental 
switch that has occurred with the move towards knowledge intensive activities and/or societies. 
Whether academia or firms are the sources of technological breakthroughs does not lie in our line of 
inquiry. But following Dasgupta and David (Dasgupta and David, 1994b), the recognition of the links 
between public and private laboratories should not lead to the denial of their differences with respect 
to their cultural background, their incentive structures, their rewards systems, etc. It follows that 
academic research units are supposed to be more active in knowledge creation than in innovation per 
se. Likewise, we might conjecture that the growing economic exploitation of given bodies of 
knowledge should lead to a higher involvement of private laboratories in knowledge development, that 
is, to a consistent rise in the number of firms involved in the economic exploitation of knowledge. 
Thus we might expect that the relative share of private laboratories in patenting rise overtime. We 
posit: 
P3: As the sector matures, the role of academic research in patenting tends to diminish 
The above propositions have been advanced at the theoretical level only. Actually, we shall be 
concerned with the analysis of the biotechnology industry, for the moment leaving apart its 
intrinsically heterogeneous nature. During the past thirty years, the life science industry (the seed, the 
agro-food, the chemical and mostly the pharmaceutical industry) has gradually awakened to the 
potential of biotechnology and has subsequently attempted to integrate and to master it. Of particular 
importance has been the emergence of new fundamental knowledge derived from molecular biology 
and genetic engineering. The rise and development of biotechnology was based on the project to 
calculate the structure and properties of biological macromolecules and cells from the physical 
interactions of their elementary components. Advances in this direction greatly improved the ability of 
researchers to rise the predictive power of the R&D activities based on the calculation of the 
functional properties of given molecules. Moreover, the convergence of molecular biology with 
information technology has brought powerful computational capabilities to biologists, allowing the 
storage and exploitation of very large-scale information sets. For instance in pharmaceuticals, new 
techniques such as high-throughput DNA sequencing, functional genomics, bioinformatics and 
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proteomics are becoming fundamental tools in modelling the structure of nucleic acids and proteins, 
thereby providing pharmaceutical researchers with new rational tools for drug development. 
Today, it is clear that the knowledge of molecular biology and genetic engineering represented a 
discontinuity with respect to the knowledge previously used in life sciences (Arora and Gambardella, 
1994, Oliver, R., 1999). The emergence of the industry was based on the exploration of large numbers 
of scientific hypothesis. A growing number of actors (academic researchers, large firms and start ups) 
has been involved in the exploration of hypotheses. Perhaps the most striking feature related to the 
development of biotechnology has been the high level of firm creation since the seventies. To date, 
more than 3,000 dedicated biotechnology firms (DBFs) have been created throughout the world, most 
of which being located in the American and in the European continents (Ernst&Young, 1998;2000). In 
our second proposition, we have argued that an industry shakeout should eventually be expected. Thus 
we now turn to another puzzling characteristic related to biotechnology, that is, inter-organisational 
collaborations and alliances. 
Actually, biotechnology has traditionally been based on close ties between the university and the 
industry (Kenney, 1986). This has many justifications. First, the very nature of biotechnological 
knowledge blurs the previously-mentioned frontier between fundamental and applied knowledge. 
Discoveries in the former may boost developments in the latter while new applications may well lead 
to new scientific breakthroughs. As a consequence, public and private laboratories have extendedly 
relied on inter-organisational arrangements as to share differentiated yet complementary knowledge. A 
second and subtler consequence of the peculiar nature of biotechnology knowledge is that university 
researchers have been in the best position to exploit the potentiality of biotechnology. Indeed, many 
DBFs were university spin-offs, being under the scientific direction of university professors, and being 
actually managed by former scientists. Altogether, it is clear that university-industry relationships in 
biotechnology have been the rule rather than the exception.  
Inter-institutional collaborations provide an extensive account of patterns of collaborations. Yet they 
do not exhaust it. Alliances with potential clients and other firms involved in biotechnology are needed 
as well (Oliver, A.L., 2001, Powell, Koput and Smith-Doerr, 1996b) generating new patterns of 
learning. Co-operations take different forms, from commercial, research or production agreements to 
joint ventures and mergers or acquisitions. Recent research on alliances and networks has stressed the 
value of inter-organisational relationship for assessing resources and creating competitive advantages 
(Dyer and Singh, 1998). The expected benefits of alliances and networks are the enrichment of the 
flow of knowledge amongst partners (Kogut, 1988), the access to complementary assets (Pisano, 
1990) as well as access to external legitimacy and status (Baum and Oliver, 1991, Liebeskind et al., 
1996). Notably, Baum et al. (Baum, Calabrese and Silverman, 2000) show that start-up’s initial 
performance increase with the size of alliance network at founding and with the efficiency of its 
alliance network at founding. The authors explain how the roles of alliance vary amongst firm age and 
size. At founding, the variation in alliance network composition produces significant differences in 
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their performance, supporting the idea that liabilities of newness and smallness result to a large extent 
from a lack of access to resources and stable exchange relationships. 
Disappointingly, such contributions do not provide a substantial account of the changing nature of the 
firms' patterns of networks over time. Our contention is that the exploitation of few promising 
scientific results must eventually lead to corresponding changes in the structure of networks. At the 
level of the firm, one may well conjecture that the network structure of a given firm changes together 
with its size, its age, or more globally its growth. Indeed, several qualitative case studies (Mcnamara 
and Baden-Fuller, 1999, Steier and Greenwood, 2000) show that the composition of collaborative 
networks in biotechnology changes as firms grow. Commercial and financial alliances become more 
vital while alliances with other firms or public laboratories gradually decrease. At the level of the 
industry, we might equally speculate that the changing nature of the technological environment leads 
to different patterns of collaboration. Notably, since firms seek to appropriate knowledge and translate 
it into private rents, be it higher productive processes or new commercial products, the role of 
collaborations in innovative activities should eventually diminish as compared to earlier research 
phases. We propose: 
P4: Collaborations and co-patenting between public and private or amongst private 
organisations tend to diminish as the industry matures. 
3. DATA AND METHODS 
Our study is based on Derwent Biotechnology Abstracts (DBA). DBA is a database covering all 
biotechnology patents applications since 1981. Today, more than 96,284 patent applications are 
reported in DBA, from 1965 to 2001 and covering 40 intellectual property authorities. Because two 
years are needed for inventory purposes, the curve drops tremendously after 1998. Therefore, the 
analysis shall exclusively be concerned with prior patents applications.  
DBA provides several information about patent applications: the name of inventors; the patent 
affiliate; the date of applications; extensive summaries; key words; etc. Computer-expensive 
manipulations were necessary in order to translate the initial DBA information set into a workable 
database format. Particular attention was paid to the patent's year of application and the name of the 
applying organisation. Predominantly demanding was the treatment of names of organisations. 
Discarding missing information condenses the database to 74,905 patent applications emanating from 
3,483 different names. Recurrent name misspelling was treated at length, while fusions and mergers 
occurring amongst firms were further taken into account. In total, 1,469 organisations were identified. 
Names provide valuable information about the institutional type of organisations. For instance, 
universities and institutes gave rise to multiple abbreviations that allowed us to easily differentiate 
public research organisations and private organisations, be they large firms or DBFs. A final ad hoc 
checking on names was performed using mainly international biotechnology directories and additional 
Internet resources, allowing us to geographically locate our sample of organisations. Altogether, 898 
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private organisations and 571 public research organisations were identified, accounting for 78% of the 
overall number of patent applications recorded in the original database.  
Here, it is worth stressing a number of observations. First, one should be aware of the fact that we are 
concentrating on a peculiar database whose coverage remains somewhat conditioned to the DBA 
definition of biotechnology. Whether a given patent application falls into DBA's boundaries of 
biotechnology is thus restricted to some subjective criteria. The important point here is that when 
actually analysing DBA patent applications, we are all the more concerned with a subset of an 
unknown exhaustive population of biotechnology patent applications. However, we are confident in 
the fact that the DBA coverage focuses on the core of biotechnology, while more technologically 
distant patent applications are discarded. Second, the modalities of actor selection imply that only 
relevant actors shall be included in the analysis. This induces that when analysing the evolution of the 
number of biotechnology actors, we are actually speaking of relevant, say important, actors, discarding 
marginal yet potentially essential other phenomena. Third, one should also keep in mind that DBA is a 
worldwide database, thus gathering different national systems of innovation together with several 
approval authorities. One of the most vivid manifestation of it lies in the relative share of bounded 
geographic areas in the total number of patent applications. Particularly, the Northern America 
accounts for more than one third of all recorded patent applications (29,009), as Japan does (27,927), 
while the European continent hardly amounts to one fifth (12,932)1. While our own knowledge of 
biotechnology conforms to the observation of the American share, we are more dubious of the Nippon 
extended share.  
Certainly, the previous remarks call for caution when commenting our results. The fact that only the 
core of biotechnology is analysed here naturally outplays additional events that, though marginal, may 
yield further discontinuities in the intra-paradigmatic development of biotechnological knowledge. 
Though aware of that, our motivation in using DBA is above all practical, conforming to a substantial 
number of other authors (Archibugi, 1992, Griliches, 1979;1990, Pavitt, 1988). DBA represents a 
unique database providing us with a chronological and systematised information set concerning both 
the rate of knowledge creation and the number of actors involved. Besides, DBA allows us to further 
describe and analyse the relationships between technical change and the underlying network structure.  
Concerning the analysis of technical change, we shall essentially give attention to the technological 
content of patent applications. Of course, there exists a multiplicity of method by which one could 
exploit such a large dataset (see notably (Frenken, 1998, Saviotti, 1988). While agreeing with the 
relevance of such methods, we focus on the technological combination of patent applications as to 
assess novelty in the so-called technological space. Indeed, DBA characterises each patent along thirty 
biotechnology-dedicated classes (see appendix 1). Theses classes were converted into a vector of 30 
technology classes, taking value 1 if technology i occurs in patent P, 0 otherwise. For example, if 
technologies A1 and A2 occur within patent P, P can be described by the 30 dimensional vector 
I = {1,1,0…0}. It follows that all patent may be described along a thirty-digit string that we call a 
                                                     
1 The remaining 5,037 patent applications come from other regions of the world.  
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technological combination or arrangement. Within one patent, a maximum of 6 technologies may be 
combined, yielding a maximum number of about 768,000 possible arrangements. Since only 2,525 
arrangements have been identified in DBA, the construction of the technological space exhibits far-
from-random explorative learning strategies. 
FIGURE 1.  Sets and Subsets in DBA.  
 By Date, Identified Actors, and Co-Patent Applications. 
Turning to the description of network structures, co-patent applications enhance the identification of 
collaborations amongst actors. Clearly, this amounts to indirectly grasp actual networks of alliances 
and collaborations. No doubts that productive alliances, licence agreements or even development 
collaborations are far from systematically leading to patenting. Moreover in the DBA database, the 
actual content of such collaborations are undoubtedly science and technology driven. Yet this is not 
prohibitive, since we are essentially interested in describing patterns of scientific and technical 
collaborations within the intra-paradigmatic construction of the biotechnology space. Co-patenting is 
all the more convenient and relevant in analysing the co-evolution of knowledge and the network 
structure. Still, a further complication lies in the method of network description. Assessing networks is 
far from straightforward. For example, graph theories have proven extremely powerful in picturing 
networks of all sorts, including interactions among technologies or actors. Furthermore, they provide 
network measures of centrality and density (Burt, 1976, Freeman, C., 1991, Freeman, L., 1979) that 
are becoming gradually used in the economics of network literature (Orsenigo, et al., 1998). But 
recalling our propositions, we shall essentially depict populations of co-patenting. Consequently, each 
Ω2=90,821
Ω4=67,464
Ω1=96,284
Ω3=70,535
Ω5=3,985
Ω6=3,822
Period 1975-1998
Original DBA
Identified actorsPeriod 1975-1998
Identified actors
Overall 
Identified  
Co-patentingPeriod 1975-1998
Identified Co-patenting
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patent has been described by the number of actors involved together with the description of their 
institutional type, namely public or private. Altogether, we have identified 7,205 co-patent 
applications, of which 3,985 have been characterised by both the numbers and the public or private 
type of partners involved. 
Figure 1 describes the whole process of sample construction throughout propositions 1-4. From the 
original 96,284 patent applications (set Ω1), the condition of relevant dates (set Ω2) and actor 
identification (set Ω3) led to 67,464 relevant patents (set Ω4). Over the whole period, 3,985 co-patents 
were identified (set Ω5), of which 3,822 belong to the 1975-1998 period (set Ω6). Because of the very 
nature of propositions 1-4, no parametric statistical test seems to be eligible in the first four 
propositions. Since we are essentially interested in the evolution of specified indicators, a longitudinal 
analysis of descriptive indicators is mobilised. Table 1 both summarises our method and reveals the 
expected outcome according the intra-paradigmatic phase under consideration. For convenience only, 
the results are presented in tables rather than in graphs.  
 TABLE 1.  Method, Indicators and Expected Outcome Through Propositions 1-4. 
 According to the Intra-Paradigmatic Phase 1 or 2. 
 Indicators Variable Phase 1 Phase 2 Table 
P1 
Evolution of the # of patents 
Evolution of the # of new arrangements 
Evolution of the Herfindhal index 
PAT 
INNO 
HERFPAT 
Increase 
Increase 
Decrease 
Decrease 
Decrease 
Increase 
Table 2 
P2 
Evolution of the # of actors 
Evolution of the Herfindhal index 
ACTOR 
HERFACT 
Increase 
Decrease 
Decrease 
Increase 
Table 2 
P3 
Evolution of the # of patents from public R&D 
Evolution of the public R&D share in patenting 
PUBPAT 
SPUBPAT 
Increase 
Increase 
Decrease 
Decrease 
Table 2 
P4 
Evolution of global co-patenting 
Evolution of public-private co-patenting 
Evolution of public-public co-patenting 
Evolution of private-private co-patenting 
COPAT 
HYBCO 
PUBCO 
PRIVCO 
Increase 
Increase 
Increase 
Increase 
Decrease 
Decrease 
Decrease 
Decrease 
Table 3 
In proposition 1 expecting a substantial slow down in knowledge creation, two indicators shall be 
mobilised, respectively the number of patents by year of application (PAT) and the number of new 
technological arrangements, or combinations, by year (INNO). Both shall be distinguished as they 
provide different types of information. The first one deals with pure knowledge creation, while the 
second one discriminate the newness in knowledge creation. New patents may be applied either 
because they consist in a radical breakthrough or because they substantially refine existing 
technological arrangements. Another important implication of the latter in that it allows us to measure 
some sort of concentration of patent applications along technological arrangements. The Herfindhal 
index, defined as the sum of the squared patent share for all technological arrangements, shall be used 
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for this purpose (HERFPAT)2. In proposition 2, we simply count the number of actors present in DBA 
for each year (ACTOR). Again, this rudimentary count measure is completed by the Herfindhal index, 
now defined as the sum of the squared patent share for all patenting organisations (HERACT). 
Proposition 3 concerns the role of academia in patent applications. Two closely related measures are 
mobilised, the first dealing with the number of patents emanating from academia (PUBPAT), the 
second presenting the relative share of patent applications from public research organisations in the 
overall patenting activity (SPUBPAT). Finally in proposition 4, the description of network structure 
shall be depicted. Three types of networks are surveyed: collaborations amongst public research 
organisations (PUBCO), collaborations amongst private firms (PRIVCO), and hybrid networks 
involving both public and private organisations (HYBCO). 
4. RESULTS 
Table 2 reports the evolution of knowledge production and the actors involved in the biotech industry, 
associated with propositions 1, 2 and 3 respectively. Focusing on the evolution of the patenting 
activity between 1975 and 1998, we observe a increasing rate of patent applications. As could be 
expected, encouraging promises of biotechnology led to a corresponding exponential rise of patent 
applications (PAT). The emergence phase did not led, however, to a slow down of patent applications. 
Rather, the rate at which patent applications increase remains continuously quite high. In other words, 
knowledge creation as expressed in patent applications does not express a yet expected declining 
phase. This crude observation may somehow be taken with caution. The evolution of the total number 
of patents presents the rhythm of the global knowledge production regardless of the technological 
novelty held in the patent. The evolution of the variable INNO provides us with the information at 
need. It shows that biotechnological novelty followed a rapid growth before 1980. Reaching its highest 
mark in 1981, its level remains steady for the remaining of the period at stake. That is in level, the 
number of new technological arrangements average around 120 new combinations each year 
introduced in the technological landscape.  
These observations lead us to conclude in the non-decreasing rate of knowledge generation, thus 
invalidating our first proposition. However, there exist various reasons for which we should remain 
careful about it. Our first reason is purely technical and reflects a database artefact. DBA introduced 
two new technology classes in 1992, thus boosting the variety of potential arrangements within the 
dataset. Though we took care in building an a-temporal nomenclature, the effect of increasing variety 
remained. Ignoring this artefact would lead to opposite conclusion. Second, the share of novelty 
(INNO) relative to patent applications (PAT) is constantly decreasing. This means that a greater part 
of knowledge generation is based on existing arrangements within the technological landscape. Third, 
                                                     
2 Other measures could well have been mobilised, namely the Gini index and the entropy measure of 
dispersion. All have in common to measure some sort of concentration (Herfindhal and Gini index) or its 
inverse, namely the dispersion (Entropy). While the magnitude of their evolution might differ from one 
method to the other, all displayed similar patterns of evolution.  
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the Hinferdhal index (HERFPAT), which describes the concentration of technological arrangements, 
decreases until 1991 revealing the novelty of knowledge created. New technological arrangements are 
introduced in the technological system as scientific hypothesis are explored. However after 1991, the 
concentration of patents by arrangements is significantly increasing, i.e. HERFPAT rises. 
Consequently, the first phase corresponds to the expansion of the technological landscape by 
explorative learning strategies, while the second is characterised by the exploitation of existing 
technological arrangements. In the latter period, new technologies tend to only marginally improve the 
existing knowledge base of the industry within the more general framework of the established 
dominant design.3 Altogether, though we remain silent regarding the rhythm of knowledge generation 
per se, we do conclude in a more established landscape.  
TABLE 2.  Descriptive Statistics for Propositions 1-3. 
 PROPOSITION 1 PROPOSITION 2 PROPOSITION 3 
 Reference Subset (Ω2) Reference Subset (Ω4) Reference Subset (Ω4)
Year PAT INNO HERFPAT ACTOR HERFACT PUBPAT SPUBPAT 
1975 27 7 68.88 15 108.03 9 0.47 
1976 53 13 59.45 31 42.74 17 0.44 
1977 106 24 35.19 49 25.62 35 0.52 
1978 165 30 26.31 85 16.09 59 0.50 
1979 475 62 21.43 146 13.84 128 0.44 
1980 1192 105 18.40 264 8.66 297 0.39 
1981 2558 168 15.29 381 9.24 519 0.29 
1982 3066 134 16.07 443 8.17 650 0.29 
1983 3683 130 16.19 528 6.72 802 0.29 
1984 3862 132 17.76 563 7.21 833 0.27 
1985 3829 73 19.38 583 7.32 845 0.28 
1986 4043 100 19.43 641 5.61 871 0.26 
1987 4655 77 20.72 715 5.15 1122 0.28 
1988 4961 98 22.70 766 4.37 1354 0.32 
1989 5028 97 24.45 803 3.87 1333 0.31 
1990 4862 99 27.58 807 3.78 1187 0.29 
1991 4730 138 16.96 778 4.01 1106 0.29 
1992 5147 127 23.43 802 3.77 1249 0.30 
1993 5167 127 27.78 821 3.81 1392 0.32 
1994 5420 110 34.58 839 3.96 1680 0.37 
1995 6322 117 36.53 852 4.16 1965 0.37 
1996 6119 134 41.95 786 4.51 1912 0.39 
1997 7476 142 41.42 761 5.69 2026 0.38 
1998 7875 133 43.25 670 5.81 2002 0.40 
 
Proposition 2 is more clearly corroborated. After an exponential rise of the number of actors involved 
in knowledge production in biotechnology until 1990, the total of actors stabilises between 1989 to 
1995 around 800 and then decreases (PAT). Thus, a gross correlation is observed between on the one 
                                                     
3 Indeed, a careful examination of patents (see appendix 1) shows a high concentration of patents in two 
central technological classes (genetic engineering and pharmaceuticals). 
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hand, the entrance of new actors with the emergence phase, that of radical advances in biotechnology, 
and on the other hand the exit of actors with the establishment of an identified dominant design. The 
latter operates as a turning point. While it greatly reduces both product and market uncertainties, it 
further designs research activities around clearly perceived technological complementarities. 
Furthermore, as innovation becomes closer to the market, firms tend to develop product and service 
through internal research to maximise the potential returns to investment. The Herfindhal index 
(HERFACT, thus concerning actors) reaches a minimum in 1992 to subsequently increase. Knowledge 
production in biotechnology is more and more concentrated around given combinations and major 
actors, though the technological landscape is still following an expanding path. 
Following Mertonian principles as guidelines (David, Mowery and Steinmuller, 1994), proposition 3 
states that as innovation gets closer to the market, academic organisations become less active in 
knowledge creation (PUBPAT, SPUBPAT). The proposition is not verified since the share of public 
research organisations in patent applications is continuously increasing from 1975 to 1998. At first 
glance, the observed advancement of the public R&D patenting is extremely puzzling. As pointed 
out by David or Callon (Callon, 1994, Dasgupta and David, 1994a), commercialisation of science 
ought not to be the central mission of public research. Since both technological arrangements and the 
number of actors reach a steady state, we would then expect public research laboratories to withdraw 
from the scene. Moreover in the meantime, firms are expected to take the lead of biotechnology 
development as they are approaching the market, hence generating turnover and profit. In fact, our 
intuition is as follows: this trend illustrates the commercialisation of science based on technological 
transfer from discovering scientists to those who will develop it commercially (Zucker, Darby and 
Armstrong, 2001). Here, the patenting of academically produced knowledge is one of the device 
used by public policies to boost technology transfer and encourage firm creation by scientists. This 
phenomenon, which conforms to our own knowledge of the field, may be one of the explanations of 
the unexpected continuous growth of the share of patent applications by public institutions. 
Table 3 presents the results on the evolving technological network structure (Proposition 4). We 
observe a positive trend for all actors until 1995. Since then, co-patenting declines rather sharply. 
Focusing amongst the institutional types of partners involved in collaborations (HYBCO, PUBCO, 
PRIVCO) reveals that this trends concerns all actors irrespective of the organisations involved in 
networking. This corroborates our proposition of a sequential increase and decrease in collaborations. 
A finer look at the figures leads to two additional observations. First, private technological alliances 
constitute the core of networking until the nineties (PRIVCO). As firms seek to appropriate knowledge 
and translate it into private rents, the role of R&D collaborations in innovative activities is diminishing 
since the beginning of the nineties. This goes together with the increasing share of individual patents 
(except in 1998). Second, collaborations amongst public research organisations become more 
important in the most recent period (PUBCO). We have previously mentioned the increasing role of 
public research in market-oriented knowledge generation activities. Its strategy becomes closer to that 
of firms in term of appropriation of scientific knowledge. We thus conclude that the emergence of 
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public patenting has been accompanied by a significant increase in collaborations amongst public 
laboratories, though their relative share in global public patent application declines. 
TABLE 3.  Descriptive Statistics for Propositions 4. 
 INDIVIDUAL PATENTS CO-PATENTING 
 Reference Subset (Ω4 – Ω6) Reference Subset Ω6 
YEAR PRIV PUB TOTAL HYBCO PRIVCO PUBCO TOTAL 
1975 5 9 14 0 0 0 0 
1976 20 15 35 0 1 1 2 
1977 29 30 59 1 1 2 4 
1978 56 48 104 1 0 5 6 
1979 158 112 270 0 1 8 9 
1980 444 271 715 6 6 10 22 
1981 1220 470 1690 18 17 15 50 
1982 1540 592 2132 8 14 25 47 
1983 1931 749 2680 19 25 16 60 
1984 2193 728 2921 30 29 36 95 
1985 2099 750 2849 37 33 28 98 
1986 2285 753 3038 28 64 44 136 
1987 2596 940 3536 59 75 55 189 
1988 2615 1129 3744 69 103 72 244 
1989 2685 1110 3795 73 75 70 218 
1990 2692 951 3643 71 79 79 229 
1991 2518 896 3414 71 81 64 216 
1992 2695 988 3683 81 83 86 250 
1993 2615 1065 3680 110 93 101 304 
1994 2640 1234 3874 116 75 149 340 
1995 2993 1498 4491 135 102 150 387 
1996 2728 1436 4164 119 71 168 358 
1997 3014 1628 4642 112 61 132 305 
1998 2802 1667 4469 85 50 118 253 
TOTAL 44573 19069 63642 1249 1139 1434 3822 
 
Our results could be summarised as follows. The evolution from emergence to maturity reveals the 
changing nature of technological exploration activities. Novelty is based on the creation of new 
arrangements reflecting the investigation of new scientific hypotheses. This phase was largely 
supported by the growth of scientific collaborations as revealed here. Note the substantial part of inter-
institutional networks (HYBCO) in which firms and academics laboratories are involved. The 
transitional or maturing phase is based on arrangements within existing combinations i.e. existing but 
disjointed technological solutions within a given technological trajectories. In the meantime during the 
most recent years, networking activities seem to decrease. Thus, relying on extra-organisational 
partners in research activities tend to be phase-specific. That is, actors share complementary 
knowledge and competencies only when the technological uncertainty and the rate of novelty are high. 
 - 16 - 
When the technologies stabilise, they develop more traditional forms of organisation in research 
activities.  
Two final remarks are worth here. First, as biotechnology appears to be a vital competence for 
innovation in life sciences, patents play a central role in the firms’ strategies. After 1980’s, the systems 
of intellectual property rights have gradually reckoned the economic potentialities of biotechnology. 
At the level of firms, stabilised and patenting has been included in firm’s strategy, especially in start-
ups’ strategy. Indeed, as pointed out by Afuah and Utterback (Afuah, A. and Utterback, 1997b), 
patents are one of the central assets needed to succeed in the emerging (fluid) phase. Dodgson 
(Dodgson, 1991) and Rabinow (Rabinow, 1996) underline that one of the condition sine qua non for 
the creation of start-ups is the opportunity to protect their innovation. Thus the observed evolution of 
patent and co-patent applications reflects more profound phenomena that go far beyond the fact of 
mere appropriation issues. It also expresses some form of adaptive efforts of a wider set of actors, 
namely regulation institutions, governmental policy makers, the cultural adjustment of and in 
academia, not to mention other aspects regarding the demand side. At an aggregate level, technical 
change necessarily involves the development of new forms of organisations and institutions 
coordinating the local and bounded activities of a wide variety of actors. 
Second, the observed declining amount of technological relationships does not necessarily deny the 
persistent role of collaborations. First DBA may principally reveal the first wave of biotechnology, 
centred on genetic sequencing and gene manipulation. And indeed, the observed evolution is well 
argued by the arrival of a set of stabilising research procedures and instruments, such as PCR, 
bioinformatics, crystallography, etc. However, recent developments in new promising areas such as 
genomics, proteomics, pharmaco-genomics and/or single nucleotide polymorphisms are still at 
infancy. We thus expect additional technological collaborations to come up in the coming years. 
Second recall that we are focusing on only technological collaborations expressed through co-
patenting. In fact, there exists a wider range of reasons for which firms, and more globally 
organisations, should enter into alliances (Hagedoorn, 1990). For example, the pharmaceutical 
industry is still witnessing a substantial number of inter-organisational ties, involving a wide variety of 
actors: DBFs, large pharmaceutical firms, and public laboratories. Large firms rely heavily on 
university ties as to improve their own knowledge base, while they call on DBFs to develop and 
explore new technical possibilities. Thus, our contention is that networks may reflect the changing 
nature of the technological landscape not in the mere number of ties, but rather in their types. In other 
words, networks are not dead. Their nature is simply changing together with the industry life cycle. 
5. DISCUSSION AND CONCLUSION 
This paper has analysed the evolution of network of technological collaborations during the life cycle 
of the industry. Based on the example of the biotech sector, it questions the network of collaborations 
as a new forms of organisations. Powell et al. (Powell, Koput and Smith-Doerr, 1996b) argue that in a 
field of rapid technological development, the locus of innovation is found within networks of 
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interorganisational relationship that sustain a fluid and evolving community. Our empirical analysis 
refreshes the Powell’s picture of networks of collaboration, in that collaborative networks are the locus 
of innovation during the exploration phase, while in a more stable environment, actors tend to rely 
more on internal learning strategies. As revealed here, collaboration is indeed the industrial 
organisation form, which allows the different actors to explore a large number of hypothesis and 
develop explorative learning in a highly uncertain environment. Such an organisation reduces risk and 
cost, while enhancing the sharing of knowledge, competencies and scientific results. Thus, 
interdependencies promote a sense of community-level mutualism (Barnett and Carroll, 1987). As the 
technological conditions change and as the sector matures, technological trajectories appear and firms 
innovate within given trajectories. The degree of novelty is reduced compared to its former level. 
Firms develop incremental innovation combining existing technologies that they acquire through 
networking in a recent past.  
However, during the exploitation phase, innovation is more based on internal R&D than in the 
unstable phase. On the one hand, firms already develop research capabilities and they are able to 
organise and perform independent research. On the other hand, as innovation is closer to the market, 
products and process directly compete within the market and co-operation is more difficult to develop. 
Networks still exist but the forms and the partnership within the network is changing. It is vital for 
firms to design collaborations with material and equipment providers as well as commercial networks. 
Whereas scientific and technological hypothesis have been explored through collaborations with 
divers organisations, i.e. start-ups, large firm, Dedicated biotech SMEs and academic labs, exploitation 
of few promising technological trajectories are developed through internal firms capabilities. The 
initial scientific and technological initial accumulation creates barriers to entry because of irreversible 
investments and because of the cumulative nature of knowledge. 
Our results are coherent with the ones obtained by Nesta and Saviotti (Nesta and Saviotti, 2002) when 
they underline the contrasted evolution of the breadth and the coherence of the knowledge base. They 
reveal two different patterns of knowledge creation and two opposite types of learning. In the fluid 
phase, it is difficult to predict the ways by which knowledge develops. Firms have to cope with high 
uncertainty and explore an expanding technological landscape by diversifying their knowledge base. 
Though in the short run, this reduces the overall coherence of the knowledge base, it mostly enhances 
higher adaptive capacity to several but poorly identified technological trajectories. As technology 
matures, firms are likely to abandon less promising competencies to concentrate on more fruitful 
competencies. Importantly the focus on fewer hypotheses that leads to the dominant design creates 
new barriers to entry for potential incumbents because of the shift from competence destroying 
process in the emerging (fluid) phase to creative accumulation in the maturing (transitional) phase. 
In the meantime, the overall industrial configuration is changing: the market introduction of 
innovation leads to more rivalry among existing competitors. Winners win new markets and grow 
while the loosers fail. Thus size becomes more and more important in reaching a critical minimum 
size as to undertake costly and heavily instrumented R&D activities. The growth of firms results from 
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internal innovations and from mergers and acquisitions, which participate to the reduction of the 
number of actors. As bio-industries become more mature, there exists evidence of a shift towards 
consolidation: 198 mergers and acquisitions have been reported in the past five years, 50% of which 
occurred in the last two years (Ernst&Young, 2001). The positive outcome of those mergers and 
acquisitions (M&A) is likely to be the emergence of an elite of European industrial biotech leaders on 
which the sector could grow and compete with that of the US, which is already mature.  
Public policies need to adapt to the phase of the life cycle of the industry and to prepare the entry into 
the next step. During the 90’s in Europe, public policy have mainly focused on three objectives: (1) 
the building of basic research capabilities to boost the rhythm of discovery in Europe; (2) 
commercialisation of R&D essentially by supporting the creation of start ups and (3) the building of 
common rules of the game to set up of a supporting environment with the harmonisation of IPR 
legislation and the creation of stock exchange for high speed growing firms. And it is quite successful. 
In less than ten years, the number of Europe firms is comparable to that of US ones. However, a rapid 
glance at the US biotech firms is in this vein extremely informative. Whereas US and Europe have a 
similar number of firms, European ones remain significantly smaller and weaker. First, regarding their 
size, European biotech SMEs represent one third of their US counterparts (61,104 versus 162,000 
employees). Second, fewer companies have gone public (105 vs. 300). Their market capitalisation 
adds up to only one fifth of their US counterparts. Third, The R&D spending and revenue streams of 
European firms lag far behind those of the US. 
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Appendix 1. The DBA Database and Technology Classes 
The Derwent Biotechnology Abstracts database defines biotechnology as: “The application of 
biological organisms and molecules to technical and industrial processes, i.e. the application of micro-
organisms, animal or plant tissue cultures, enzymes, or any other cellular or sub-cellular biological 
system, to the production of pharmaceuticals, pesticides, chemicals, enzymes, single cell protein, 
energy, etc., on an industrial scale.  Includes both de novo biosynthesis and specific biochemical 
modification of previously synthesized compounds.” The following scientific items are covered in 
DBA: “Molecular biology and genetics, recombinant DNA techniques, cell fusion in plants, animals 
and microbes, animal and plant cell and tissue culture, micro-manipulation of embryos, molecular and 
cellular immunology, enzyme, organelle and whole cell immobilization, protein and enzyme 
engineering, fermentation technology and process engineering, including computerization.” For each 
patent, the database indicates the patent holder (corporate affiliate), the year of applications and the 
technological areas to which the patent has been assigned. Because areas are listed, the conversion of 
the database into a workable format was needed. Notably, rather than having a list of the technological 
areas covered in a given patent, a vector of thirty technologies was assigned to all patents. This 
provided us with the raw material for further empirical manipulations. Descriptive statistics for each 
technology classes are found in table A1, covering the period 1981-1997. 
TABLE A1 Descriptive Statistics for DBA Technological Occurrences 
Classes principales Classes secondaires Mean frequency Global Growth 
Rate 
A-genetic-engineering-and-fermentation A1-Nucleic-Acid-Technology A2-Fermentation 60,5 + 482,1 
B-engineering B1-Biochemical-Engineering 6,7 - 38,1 
C-analysis C1-Sensors-and-Analysis 3,2 + 42,7 
D-pharmaceuticals 
D1-Antibiotics 
D2-Hormones 
D3-Peptides-and-Proteins 
D4-Vaccines 
D5-Other-Pharmaceuticals 
D6-Antibodies 
D7-Clinical-Genetic-Techniques 
54,8 + 555,0 
E-agriculture 
E1-Biological-Control-Agents 
E2-Plant-Genetic-Engineering 
E3-Pesticides 
E4-In-Vitro-Propagation 
E5-Agricultural,-Other 
9,6 + 669,6 
F-food F1-Food-and-Food-Additives 9,6 - 15,8 
G-fuels,-mining-and-metal-recovery G1-Biofuels-and-Solvents G2-Mining-and-Metal-Recovery 13,6 - 28,0 
H-other-chemicals 
H1-Polymers 
H2-Chiral-Compounds 
H3-Miscellaneous-Compounds 
H4-Polyunsaturates 
6,4 + 185,6 
J-cell-culture J1-Animal-Cell-Culture J2-Plant-Cell-Culture 16,0 + 229,4 
K-biocatalysis K1-Isolation-and-Characterization K2-Application 25,6 + 75,8 
L-purification L1-Downstream-Processing 7,5 - 77,0 
M-waste-disposal-and-the-environment M1-Industrial-Waste-Disposal M2-Environmental-Biotechnology 7,1 + 103,0 
Source: Derwent Biotechnology Abstract. 
 
